◆ 会议时间:2022年9月23日至25日
◆ 会议地点:美国 - 芝加哥(Chicago, USA)
◆ 会议简介:
2022年IASLC北美洲肺癌大会(NACLC2022)将于2022年9月23日至25日在美国芝加哥举行,会议由国际肺癌研究协会(IASLC)主办,预计有1000名代表出席现场会议。
国际肺癌研究协会(IASLC)成立于1974年,是全球唯一致力于肺癌研究的组织,由致力于肺癌领域研究的专家们发起和创立,成员包括来自于全球100多个国家的5000多名肺癌专家。IASLC在肺癌和其他胸部恶性肿瘤的病因学、流行病学、预防、诊断、治疗以及与之相关宣的领域开展深入研究,为医学团体与大众服务。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)
IASLC 2022 North America Conference on Lung Cancer (NACLC2022)
Date: Sep 23-25, 2022
Venue: Chicago, IL, USA
OVERVIEW
The NACLC 2022 is a dynamic meeting with a long tradition. Learn about the latest developments in prevention, detection, and care with novel data presentations.
摘要征集-Call for Abstracts
Important Deadlines
May 16, 2022 |
Abstract Submission Opens |
June 17, 2022 (23:59 PST) |
Abstract Submission Deadline |
July 22, 2022 |
Abstract Notifications of Acceptance/Rejection |
August 19, 2022 |
Presenting Author Registration Deadline |
Abstract Submission Guidelines
- Research work should be original and innovative. Work can be presented prior to the IASLC 2022 North America Conference on Lung Cancer Meeting but MUST include new information/data.
- Abstract title must not exceed 100 characters in length.
- Abstracts must not exceed 400 words in length (not including title and authors).
- Tables may be included, and each will count as 100 words.
- A maximum of two images may be included; each will count as 100 words.
- Tables, images and graphs must be uploaded in GIF, JPEG, JPG or PNG format at 300 dpi and 100% size. Any higher resolution is acceptable.
- Abstracts must be structured with the following headings:
- Background
- Methods
- Results
- Conclusion
- Please add the above headings (Background, Methods, Results, Conclusion) to each section of your abstract body.
- Abstracts will be accepted in English only
- There is no fee for submitting an abstract
- There is no limit to the number of abstracts you may submit (however an individual may not be offered more than one poster or oral presentation)
- Special consideration will be given to authors < 4 years from completion of fellowship training (no proof required)
- Encore Submission: An abstract that has previously been presented at another meeting will only be considered if there have been significant updates to the abstract. Submitters are required to list any previously presented abstracts in the introduction of the abstract.
- Trial in Progress: NACLC accepts the submissions of trials in progress.
- Financial disclosure and affiliation information is required for the presenting author.
- Publication: Authors must agree to allow publication of accepted abstract(s) in the Journal of Thoracic Oncology (JTO) and the conference website. Most abstracts will be published and released prior to the meeting, except for embargoed abstracts which will be posted on the day of presentation.
Independence of Educational Activity
- Employees of ACCME defined ineligible companies are prohibited from presenting educational content for Continuing Medical Education. Consequently, employees of ineligible companies are prohibited from giving presentations during accredited CME sessions.
- In situations where the presenting author is an employee of an ineligible company, the abstract will automatically be considered for a poster.
- Presenting authors must be registered for NACLC 2022 independent of an ineligible company,except foremployees of ineligible companies, who are allowed to be registered by their employers.
- Presenting author must control all content. Ineligible companies may not influence scientific content by requiring the use of company slide decks or other materials. Scientific data generated by industry sponsored research is permissible.
- Content of educational activities must be well-balanced, evidence based and unbiased. Generic names should be used to the extent possible.
- Ineligible companies/commercial interests may not submit registration materials or fees on behalf of learners, faculty or others attendee types.
Step 1. Title, Topic and Presentation Type
- The abstract title must not exceed 100 characters in length.
- Please select the desired topic for your abstract submission. The scientific program committee reserves the right to move the abstract to another topic should it be seen as a better fit.
- Please note your preferred presentation format. If you would not be comfortable giving an oral presentation, please select Poster Only. NOTE: Selecting Poster/Oral does not guarantee you will be assigned an oral abstract presentation upon acceptance; the final presentation type is determined by the Scientific Program Committee
Step 2. Authors
- Please enter the authors and affiliations of the abstract in title case.
- Only abstract submissions from Junior Faculty (trainees, fellows, PhD students, faculty members in their first two years in an academic position.) will be accepted. Proof of junior faculty status (acceptance letter, university ID, letter of employment etc.) will be requested during abstract submission.
- There is no limit to the number of co-authors per abstract
- There is a limit of one presenting author per abstract
- If more than two authors are listed, please select who the presenting author is.
- The presenting author of an accepted abstract must be registered by August 19, 2022
- Should a presenting author not be registered by the deadline the abstract may be removed from the program.
Step 3. Abstract Text
- Do not include Title or Author data in the body of your abstract. Title and author should be entered in the steps above.
- Abstracts may be entered directly into the site or copied and pasted
- Research work should be original and innovative. Work can be presented prior to the IASLC 2022 North America Conference on Lung Cancer, but MUST include new information/data
- Abstracts must not exceed 400 words in length (not including title and authors)
- Tables may be included, and each will count as 100 words
- A maximum of two images may be included; each will count as 100 words
- Tables, images and graphs must be uploaded in GIF, JPEG, JPG or PNG format at 300 dpi and 100% size. Any higher resolution is acceptable.
- Abstracts must be structured with the following headings:
- Background
- Methods
- Results
- Conclusion
- Please add the above headings (Background, Methods, Results, Conclusion) to each section of your abstract body. These headings will not count towards your word limit of 500.
Step 4. Preview & Submit
- Please proofread your submission prior to submitting
- Once an abstract is submitted it cannot be deleted, modified or corrected in the system after submission. All submitted abstracts will be published exactly as submitted.
- Any abstracts in “Draft” status after the submission deadline has passed will not be considered for review. It is the abstract submitters responsibility to ensure that all abstracts you wish to be reviewed have been properly submitted.
- Should you need to withdraw a submitted abstract, please contact naclc2022-program at icsevents.com. Please include the abstract number and abstract title in your email.
- Please carefully review the affiliation of all your co-authors as this is how it will appear in the conference program book as well as on the conference website.
- You will be asked to review and agree to the abstract submission terms & conditions prior to submitting your abstract. Please read the information carefully.
For inquiries, please contact naclc2022-program@icsevents.com. If your inquiry is regarding a particular draft or submission, please include the abstract number and title in your email.
◆ 参会对象:
诊断和治疗肺癌患者的医疗保健专业人士,包括临床医生,肿瘤内科医生,科学家,胸外科医生,呼吸科/肺科医师,放射肿瘤学家,放射学家,病理学家,介入放射科医师,基础研究科学家、流行病学家以及高级执业护士和医师助手,以及其他相关专业人士代表。
|